The goal of this session is to help clinicians and other service providers understand the regional and national picture of HCV infection in the population of people in recovery. For those seeking treatment for addiction in a medication-assisted treatment (MAT) program, medical professionals can also assist with a treatment regimen for the HCV infection utilizing a number of new treatment options. Current studies underway in New York State, appear to indicate that by making HCV and MAT medications available at the same point of contact, the patient/caregiver relationship can be leveraged to better insure that the patient will seek and receive treatment for their Hep C infection. This can be done via telemedicine, with pretreatment testing done at the addiction treatment location, followed by administration of the appropriate HCV medications and methadone in an observed setting.
At session completion, attendees should be able to:
Increase HCV testing, diagnosis, counseling and treatment in PWIDs
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV in the population
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Register here: https://www.cvent.com/d/j8qv85